Plain-English translation of NCT07094919 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying the Corheart 6, a mechanical heart pump device that is implanted surgically to help the left side of the heart pump blood more effectively. The study will follow patients who have received this device since late 2021, or who plan to receive it, to learn how well it works and what side effects people may experience over 6 months to 2 years.
Severe heart failure that doesn't improve with medications alone can be life-threatening. This treatment is designed to help patients whose hearts can no longer pump enough blood on their own, potentially giving them more time and better quality of life while they wait for a heart transplant or their heart recovers.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have already received the Corheart 6 device through surgery, or will receive it as part of your clinical care. The study then involves regular follow-up appointments where doctors will check your heart function, test your blood, ask about your quality of life and any side effects, and track your survival and recovery over 6 months and 2 years. You'll be asked to come back for scheduled visits and possibly some additional testing to help researchers understand how well the device is working for you.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
China